I believe that a reverse-split is warranted (consolidation of outstanding shares) in order to relist on the NASDAQ.

Transparency in current testing and a timeline should be released to encourage investor confidence.

NNLX should actively be seeking to be acquired shortly after their N-Assay release date.

If all of these events happen then I believe NNLX will pay off.

I am interested to hear thoughts.